Development Level

Tbio 4 | 10,625
Tchem 3 | 1,890
Tclin 1 | 602

IMPC Term

abnormal gait 1 | 51
embryonic lethality prior to t... 1 | 187
increased circulating potassiu... 1 | 31
preweaning lethality, complete... 1 | 633

Disease

Hyperglycemia 7 | 120
Hyperinsulinism 7 | 63
Metabolic syndrome X 7 | 155
Obesity 7 | 616
diabetes mellitus 7 | 1,663
Diabetes Mellitus, Non-Insulin-Dependent 6 | 157
Alzheimer's disease 5 | 644
Cancer 5 | 2,346
Fatty liver disease 5 | 84
Arthritis 4 | 248
Heart disease 4 | 279
Hypertensive disease 4 | 193
Insulin Resistance 4 | 48
Kidney disease 4 | 396
Lipid metabolism disorder 4 | 102
Lipodystrophy 4 | 32
Liver disease 4 | 219
Osteoporosis 4 | 257
Polycystic Ovary Syndrome 4 | 332
intraductal papillary-mucinous neoplasm (IPMN) 4 | 3,289
invasive ductal carcinoma 4 | 2,950
ovarian cancer 4 | 8,484
psoriasis 4 | 6,685
Adenoma 3 | 165
Asthma 3 | 349
Atherosclerosis 3 | 275
Cerebrovascular disease 3 | 231
Colonic Neoplasms 3 | 126
Coronary artery disease 3 | 240
Diabetes Mellitus, Experimental 3 | 106
Fatty Liver 3 | 48
Hypertension 3 | 287
Hypoglycemia 3 | 81
Inflammation 3 | 109
Lung disease 3 | 132
Mammary Neoplasms 3 | 410
Prostatic Neoplasms 3 | 471
Schizophrenia 3 | 501
Seizures 3 | 95
Vascular disease 3 | 281
breast carcinoma 3 | 1,614
ductal carcinoma in situ 3 | 1,745
intraductal papillary-mucinous carcinoma (IPMC) 3 | 2,988
osteosarcoma 3 | 7,933
Acanthosis nigricans 2 | 14
Acute kidney injury 2 | 65
Amenorrhea 2 | 60
Anovulation 2 | 20
Atopic dermatitis 2 | 944
Brain disease 2 | 83
Breast cancer 2 | 3,094
Cardiomegaly 2 | 66
Cataract 2 | 104
Colon Carcinoma 2 | 25
Colorectal Neoplasms 2 | 217
Crohn Disease 2 | 97
Degenerative polyarthritis 2 | 93
Diabetic Retinopathy 2 | 53
Epilepsy 2 | 346
Hyperandrogenism 2 | 32
Hyperinsulinemic hypoglycemia 2 | 17
Hyperthyroidism 2 | 50
Hypogonadism 2 | 70
Hypothyroidism 2 | 89
Infertility 2 | 163
Inflammatory bowel disease 2 | 142
Liver carcinoma 2 | 217
Metabolic Diseases 2 | 9
Myopathy 2 | 128
Nerve Degeneration 2 | 73
Obesity, Morbid 2 | 6
Obstructive sleep apnea 2 | 28
Parkinson's disease 2 | 364
Prader-Willi syndrome 2 | 45
Tachycardia 2 | 17
adrenocortical carcinoma 2 | 1,427
cystic fibrosis 2 | 1,665
esophageal adenocarcinoma 2 | 737
fibroadenoma 2 | 557
interstitial cystitis 2 | 2,299
intraductal papillary-mucinous adenoma (IPMA) 2 | 2,956
lung adenocarcinoma 2 | 2,713
lung cancer 2 | 4,466
lung carcinoma 2 | 2,844
malignant mesothelioma 2 | 3,162
medulloblastoma, large-cell 2 | 6,234
non-small cell lung cancer 2 | 2,798
ovarian neoplasm 2 | 97
pancreatic cancer 2 | 2,300
primitive neuroectodermal tumor 2 | 3,031
tuberculosis 2 | 1,557
ulcerative colitis 2 | 2,087
Adenomatous Polyposis Coli 1 | 10
Barrett Esophagus 1 | 16
Hemangioma 1 | 35
Hypotension 1 | 53
Mood disorder 1 | 10
Neurofibromatosis 1 | 37
Type 1 diabetes mellitus 1 | 101
maturity-onset diabetes of the young 1 | 28

Tissue

Blood and immune system 8 | 17,995
Cardiovascular System 8 | 17,958
Digestive Tract 8 | 18,473
Endocrine System 8 | 18,512
Female tissues 8 | 18,647
Liver and Pancreas 8 | 18,136
Male tissues 8 | 17,969
Nervous System 8 | 18,561
Skin and soft tissues 8 | 18,115
Urinary Tract 8 | 18,444
Respiratory system 7 | 17,484

Target Family

Non-IDG 3 | 11,971
Transporter 3 | 473
Kinase 1 | 634
Nuclear Receptor 1 | 48

Grant Application

5R01HL058119-05 8 | 8
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Solute carrier family 2, facilitated glucose transporter member 4 SLC2A4 Tchem Transporter -3.30074 2066.8 474
Insulin INS Tbio Non-IDG -5.14691 141255.4 1549
Peroxisome proliferator-activated receptor gamma PPARG Tclin Nuclear Receptor -3.91275 8950.6 711
Solute carrier family 2, facilitated glucose transporter member 8 SLC2A8 Tbio Transporter -1.49249 34.8 97
Solute carrier family 2, facilitated glucose transporter member 1 SLC2A1 Tchem Transporter -3.40027 2531.3 392
Mitochondrial uncoupling protein 2 UCP2 Tbio Non-IDG -2.96546 1022.7 208
RAC-alpha serine/threonine-protein kinase AKT1 Tchem Kinase -4.29533 18275.3 3137
Leptin LEP Tbio Non-IDG -4.13745 15277.2 796